The investment round, valued at close to 100 million renminbi, or $13.8 million, was led by L'Oréal's China fund, its ...

The Beachwood-based company announced on Tuesday, May 20, that it has appointed Dr. David Llewellyn as its new CEO and as a ...

Dr. Aaron Carrithers brings a founder’s mindset and extensive firsthand experience, guiding biotech teams through complicated ...

Biotechs have faced several challenging years with slumping valuations and a competitive funding environment. However, the latest slew of ...

Biotechnology has become the backbone of data-driven healthcare. With this advancement comes significant ethical and security ...

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Developed by ALX Oncology's protein engineers utilizing the Company's proprietary topoisomerase I inhibitor payload and ...

Cuts to funding risk hobbling Boston’s science establishment ...

Operator: Good afternoon, and welcome to Oncolytics Biotech First Quarter Conference Call. All participants are in a listen-only mode.